Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil in Mild Cognitive Impairment
NCT07882901Phase 2Not yet recruiting
- Sponsor
- Los Angeles Brain Science Project
- Start
- Sep 2026
- Primary completion
- Feb 2027
- Countries
- 1
01
Overview
A Phase 2 trial of tadalafil in Mild Cognitive Impairment (MCI), sponsored by Los Angeles Brain Science Project. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
tadalafil
03
Conditions
Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on NCT07882901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07882901.